Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael D Hill, MD MSc
University of Calgary
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
50 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Adelaide Hospital
Adelaide, Australia
- Royal Melbourne Hospital
Parkville, Australia
- University of Calgary - Foothills Medical Centre
Calgary, Alberta, Canada
- University of Alberta Hospital
Edmonton, Alberta, Canada
- Vancouver Stroke Program Research Office/ Vancouver General Hosptial
Vancouver, British Columbia, Canada
- Queen Elizabeth Ii Health Science Centre
Halifax, Nova Scotia, Canada
- Hamilton General Hospital
Hamilton, Ontario, Canada
- London Health Sciences Centre- University Hospital
London, Ontario, Canada
- the Ottawa Hospital
Ottawa, Ontario, Canada
- St Michael'S Hospital
Toronto, Ontario, Canada
- Sunnybrook Health Centre
Toronto, Ontario, Canada
- University Health Network - Toronto Western Hospital
Toronto, Ontario, Canada
- Chum Hopital Notre-Dame
Montreal, Quebec, Canada
- Montreal Neurological Institute and Hospital
Montreal, Quebec, Canada
- Chu de Quebec- Universite Laval- Hopital de L'Enfant-Jesus
Québec, Quebec, Canada
- Royal University Hospital
Saskatoon, Saskatchewan, Canada
- Universitätsklinikum Carl Gustav Carus Dresdner Neurovaskulares Centrum
Dresden, Germany
- Klinik Für Radiologie Und Neuroradiologie
Essen, Germany
- University Medical Center Goettingen
Göttingen, Germany
- Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany
- Neurologische Klinik, Universität Heidelberg
Heidelberg, Germany
- Beaumont Hospital
Dublin, Ireland
- Mater Hospital
Dublin, Ireland
- Dongsan Medical Centre
Daegu, South Korea
- Inha University Hospital
Incheon, South Korea
- Samsung Medical Center
Seoul, South Korea
- Yonsei Univ, Severence
Seoul, South Korea
- Skåne University Hospital
Lund, Sweden
- Karolinksa Institutet
Stockholm, Sweden
- Royal Victoria Hospital
Belfast, United Kingdom
- Ronald Reagan Ucla Medical Center
Los Angeles, California, United States
- California Pacific Medical Center - Davies Campus
San Francisco, California, United States
- Providence Little Company of Mary Medical Center Torrance
Torrance, California, United States
- Swedish Medical Center
Englewood, Colorado, United States
- Yale New Haven Hospital
New Haven, Connecticut, United States
- Baptist Health Medical Center
Jacksonville, Florida, United States
- Grady Memorial Hospital
Atlanta, Georgia, United States
- Wellstar Health Systems
Marietta, Georgia, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Massachusetts Medical School
Worcester, Massachusetts, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Mar 2017
- Primary completion
- 20 Nov 2019
- Completion
- 20 Nov 2019
- Last update posted
- 10 Oct 2022
- Registered enrollment
- 1,105
- Registry id
- NCT02930018
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.